Nicolas Albin

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Ejection Fraction

Top Venues

Cancer chemotherapy and pharmacology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Fiona Y-V Pham, Emmanuelle Jacquet, Amina Taleb, Adrien Monard, Ghania Kerouani-Lafaye, Florence Turcry, Liora Brunel, Françoise Grudé, Isabelle Yoldjian, Isabelle Sainte-Marie, Lotfi Boudali, Jean Yves Blay, Nicolas Albin
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019. International journal of cancer 151 (8) (2022)
Claire Christen, Laetitia Belgodère, Bernard Guillot, Céline Jumeau, Annie Lorence, Ghania Kerouani-Lafaye, Liora Brunel, Florence Turcry, Adrien Monard, Francoise Grudé, Gaëlle Guyader, Lotfi Boudali, Nicolas Albin
Access to innovation through the national early access program and clinical trials for patients with malignant melanoma. Cancer 127 (13) (2021)
Nicolas Albin, Adrien Monard, Jérémy Lapiere
The clinical added value of the addition of anti-CTL-4 to anti-PD-1 alone is questionable and clearly increasing toxicity regarding pivotal studies in the treatment of melanoma and renal carcinoma. Cancer chemotherapy and pharmacology 83 (5) (2019)